Antisocial Personality Disorder: Clinical Trials

8 trials for Antisocial Personality Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 unknown. 8 Phase 2, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Completed 7, Unknown 1
Phase 35Completed 5

Follow Antisocial Personality Disorder: new trials by email Literature Review of Antisocial Personality Disorder trials Research Report on Antisocial Personality Disorder

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Omega-3 Supplementation and Behavior Problems
Omega-3 supplemented drink, Smartfish - Aggression, Antisocial Behavior
Phase 2 / Phase 3CompletedDr. Annis Fung3242015-02-012018-07-18
Working Memory Training in Adults With Substance Abuse and Executive Function Deficits.
Computerized Cogmed working memory training, Treatment as usual - Substance Abuse, Executive Dysfunction
Phase 2UnknownÖrebro Läns Landsting1002014-01-012015-10-23
Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function
Vitamin C +prenatal vitamin, Placebo tablet+prenatal vitamin - Pulmonary Function; Newborn, Abnormal, Infant Wheeze
Phase 2 / Phase 3CompletedOregon Health and Science University2522012-12-012019-04-17
Omega-3 Supplements to Reduce Antisocial Behaviour in Young Offenders
Omega-3, Placebo, Treatment as Usual - Antisocial Behavior
Phase 2 / Phase 3CompletedSingapore Prison Service1812011-03-012018-08-13
Effect of Omega-3 Supplementation on Child Behavior Problems
omega-3 - Antisocial, Aggressive
Phase 2 / Phase 3CompletedJoint Child Health Project, Mauritius2002010-03-012013-12-19
The Impact of Psychopathic Traits on the Efficacy of a Substance Use Intervention
motivational enhancement therapy, standard care - Substance Use, Psychopathy
Phase 2CompletedUniversity of Rochester1052009-08-012016-12-12
Feasibility of Delphi Screener for Cervical Cytology
Delphi Screener - Cervical Neoplasia
Phase 2CompletedColumbia University1982008-09-012014-01-13
Personality-targeted Interventions for Adolescent Alcohol Misuse
PRE-Venture: Personality Risk Education - Alcohol Abuse, Drug Abuse
Phase 2 / Phase 3CompletedKing's College London7102003-11-012011-06-27

Narrower conditions

Substance-Related Disorders (3)  ·  Aggression (2)  ·  Anxiety Disorders (2)  ·  Depression (2)  ·  Alcoholism (1)  ·  Behavior, Addictive (1)  ·  Binge Drinking (1)  ·  Conduct Disorder (1)  ·  Dyslexia (1)  ·  Mental Disorders (1)  ·  Panic Disorder (1)  ·  Recidivism (1)  ·  Respiratory Sounds (1)

Broader conditions

Personality Disorders (8)  ·  Mental Disorders (7)  ·  Behavior (5)  ·  Behavioral Symptoms (4)  ·  Chemically-Induced Disorders (3)  ·  Aberrant Motor Behavior in Dementia (2)  ·  Neurodevelopmental Disorders (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Social Behavior (2)  ·  Alcohol Drinking (1)  ·  Alcohol-Related Disorders (1)  ·  Attention Deficit and Disruptive Behavior Disorders (1)  ·  Communication Disorders (1)  ·  Compulsive Behavior (1)

Interventions

Docosahexaenoic Acids (2)  ·  Therapeutics (2)  ·  Ascorbic Acid (1)  ·  Motivational Interviewing (1)  ·  Standard of Care (1)

Sponsors

Columbia University (1)  ·  Dr. Annis Fung (1)  ·  Joint Child Health Project, Mauritius (1)  ·  King's College London (1)  ·  Oregon Health and Science University (1)  ·  Singapore Prison Service (1)  ·  University of Rochester (1)  ·  Örebro Läns Landsting (1)

Countries

United States (3)  ·  China (1)  ·  Mauritius (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Adrian Raine (1)  ·  Annis Fung, Ph.D. (1)  ·  Carolyn Westhoff, MD (1)  ·  Cynthia T McEvoy, MD,MCR (1)  ·  Cyril Dalais, MSc (1)  ·  Lars Kjellin, Docent (1)  ·  Marc T. Swogger, Ph.D. (1)  ·  Patricia J. Conrod, Ph.D. (1)  ·  Tashneem Moohamed, BSc (1)

Results publications

PMID 20048226, PMID 20732631, PMID 20869813, PMID 24376516, PMID 25146492, PMID 26727409, PMID 30522343, PMID 30865304, PMID 34538263, PMID 38413986, PMID 41044653

NIH funding

K23DA027720 (1), R01HL105447 (1)